Cardiovascular Research Advance Access [Accepted Manuscript] published online on December 12, 2007
Cardiovascular Research, doi:10.1093/cvr/cvm100
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disruption of PLCgamma1 Signalling Attenuates Cardiac TNF-alpha Expression and Improves Myocardial Function during Endotoxemia


1 Center for Critical Illness Research, University of Western Ontario, London, Ontario, Canada
2 Lawson Health Research Institute, Department of Medicined, University of Western Ontario, London, Ontario, Canada
3 Department of Pathology, University of Western Ontario, London, Ontario, Canada
4 Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario, Canada
Correspondence to: Dr. Tianqing Peng, Center for Critical Illness Research, Lawson Health Research Institute, VRL 6th Floor, A6-140, Commissioners Road, London, Ontario, Canada N6A 4G5 Tel. (519) 685-8300 Ext. 55441. Fax (519) 685-8341. E-mail: tpeng2{at}uwo.ca Or Dr. Qingping Feng, Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario, Canada N6A 5C1. Tel. (519) 850-2989. Fax (519) 661-4051. E-mail: qfeng{at}uwo.ca
Aim: Lipopolysaccharide (LPS) induces tumor necrosis factor-
(TNF-
) expression in cardiomyocytes, which contributes to myocardial dysfunction during sepsis. The purpose of this study was to investigate the role of phosphatidylinositol (PI) phospholipase C
1 (PLC
1) in cardiac TNF-
expression and myocardial dysfunction during endotoxemia.
Methods and Results: In cultured mouse neonatal cardiomyocytes, LPS increased PLC
1 phosphorylation. Knockdown of PLC
1 with specific siRNA or inhibition of PLC
1 with U73122
[GenBank]
attenuated TNF-
expression induced by LPS. This action of PLC
1 was mediated through inositol-1,4,5-trisphosphate (IP3)/IP3 receptor (IP3R) pathways since blocking either IP3 or IP3R decreased LPS-induced TNF-
expression. In contrast, neither diacylglycerol agonist nor antagonist had any evident effect on LPS-induced TNF-
expression in cardiomyocytes. To investigate the role of PLC
1 in endotoxemia in vivo, wild-type and heterozygous PLC
1 knockout (PLC
1+/-) mice were pre-treated with either U73122
[GenBank]
, or its inactive analog U73343
[GenBank]
, or vehicle for 15 min, followed by LPS for 4 h. Inhibition of PLC
1 by U73122
[GenBank]
or by heterozygous deletion of the PLC
1 gene decreased cardiac TNF-
expression. More importantly, LPS-induced myocardial dysfunction was also attenuated in PLC
1+/- mice or by U73122
[GenBank]
treatment.
Conclusions: PLC
1 signaling induces cardiac TNF-
expression and myocardial dysfunction during LPS stimulation. The action of PLC
1 on TNF-
expression is mediated through IP3/IP3R pathways. The present results suggest that PLC
1 may be a potential therapeutic target for myocardial dysfunction in sepsis.
Time for primary review: 32
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Li, Y. Li, Q. Feng, M. Arnold, and T. Peng Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes Cardiovasc Res, October 1, 2009; 84(1): 100 - 110. [Abstract] [Full Text] [PDF] |
||||
